Question follow-through · 23198
Pancreatic Enzyme Replacement Therapy
To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that (a) patients requiring Creon are updated on the availability of that medication and (b) local guidance issued by (i) his Department and (ii) NHS England is shar
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 10 Jan 2025
- Target answer date
- 14 Jan 2025
- Answer
- 15 Jan 2025 · 5 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Health Services · 3 Feb 2025
- Ehlers-Danlos Syndrome: Health Services · 25 Feb 2025
- Ruxolitinib · 25 Feb 2025
- Neurodiversity: Children and Young People · 18 Mar 2025
- General Practitioners: Pay · 18 Jun 2025
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
10 Jan 2025
Question tabled
To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that (a) patients requiring Creon are updated on the availability of that medication and (b) local guidance issued by (i) his Department and (ii) NHS England is shar
14 Jan 2025
Target answer date
Date supplied by the official written-questions record.
15 Jan 2025
Answer published
The Department has been working with suppliers, NHS England, and national clinical specialists to address the current supply issues with Creon, which is a brand of pancreatic enzyme replacement therapy. Comprehensive guidance has been issued to the Nation...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Health Services
3 Feb 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of (a) public health services and (b) adult social care on demand for (i) primary and (ii) acute NHS services.
Ehlers-Danlos Syndrome: Health Services
25 Feb 2025 · To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that people with Ehlers-Danlos Syndrome receive adequate medical support.
Ruxolitinib
25 Feb 2025 · To ask the Secretary of State for Health and Social Care, whether he plans to (a) utilise the complex patient access scheme to make Ruxolitinib available on the NHS and (b) consider other options for vitiligo patients to receive that medication.
Neurodiversity: Children and Young People
18 Mar 2025 · To ask the Secretary of State for Health and Social Care, what steps he is taking to help reduce the waiting times for diagnosis of (a) autism and (b) ADHD for children and young people.
General Practitioners: Pay
18 Jun 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of whether the 7.4 per cent global sum uplift for 2024-25 will sufficiently cover the accepted recommendation of a 6 per cent pay rise for GP partners and salaried staff
Addictions: Death
4 Mar 2026 · To ask the Secretary of State for Health and Social Care, what processes are in place to ensure that findings from Safeguarding Adult Reviews (SARs) involving addiction related deaths are embedded consistently in national guidance, NHS workforce training,
Addictions
4 Mar 2026 · To ask the Secretary of State for Health and Social Care, whether the Government plans to include addiction or substance use disorder within the statutory definition of a mental disorder for the purposes of the Mental Health Act.